chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4/23/21- I asked the patient to come into the office because he has a history of pneumonia which was fairly severe and he developed a cough and congestion.  He also had the J&J COVID-19 vaccine five weeks ago and last night symptoms did not seem like COVID-19  Today in the office his temperature was 36.3 and he's now having a headache fairly significant, global and his girlfriend stayed said he had a sense change smelling garlic yesterday. Patient downplayed that. His cough is nonproductive. He's not short of breath although his endurance is much worse today.  He did take some Mucinex D the last two or three days with some affect. Vital Signs Temp 97.3, RR 18, HR 90, Ht 70. Examination General Examination:  General examination found him well-developed well-nourished he seemed a little congested did not appear short of air otherwise in no acute distress.  HEENT examination revealed some congestion turbinates no x-rays noted. Throat was not injected.  Neck examination no adenopathy to palpation no tenderness no nuchal rigidity.  Lungs are course but good air movement throughout no real wheezing noted  Cardiovascular emanation regular rate and rhythm 88 bpm  A COVID-19 rapid antigen test was performed by myself in both nostrils using sterile technique and it returned positive. Assessment 1. COVID-19  U07.1 (Primary), 5 weeks s/p J and J vaccine. Moderately ill with HA, congestion/abnormal smell yesterday, fever yesterday, treatment mostly supportive. Dulera inhaler two puffs BID rinse after tylenol,advil,mucinex D prn, Nyquil at h.s. cough medicine if needed (patient has at home.) 2. Cough  R05
He is 17 and received the 1st dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (He is 17 and received the 1st dose of the vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (He is 17 and received the 1st dose of the vaccine). On 06-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (He is 17 and received the 1st dose of the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   This case was linked to MOD-2021-114368 (Patient Link).
No Adverse Event Reported. Provider gave Kinrix instead of Infanrix. Kinrix was given at a long enough interval to count as the 4th Polio and 5th Dtap.
Situation: Pt is present for appointment for 1st dose of Pediatric Pfizer Covid vaccination. Background: Dose is administered by MA at 1540 with discharge time of 1555. Pt and mom comes to RN with c/o redness and rashes on antecubital areas bilaterally at 1600.  Assessment: Patient is taken to observation area with mom and is given icepacks to apply bilaterally. Initial vital signs at 1605 are 104 HR, 98/67 BP, 20 RR 99% o2 @ RA. Patient denies SOB, difficulty breathing, or chest pain on assessment and is calm watching tablet with mother at side. Redness remains on antecubital areas bilaterally, is also seen faintly on neck and R orbital area. V/S at 1615 110 HR, 96/65 BP, 20 RR 99% o2 @ RA. Redness remains localized. Pt denies SOB, difficulty breathing and chest pain, remains calm watching tablet with mother. V/S @1637 are 101 HR, 93/63 BP, 20 RR, 100% o2 @ RA. Pt denies SOB, difficulty breathing and chest pain, remains calm watching tablet with mother. Redness remains localized. Mom denies Epinephrine administration when offered, states that Zyrtec might work better. V/S @ 16:55 96 HR, 94/57 BP, 20 RR, 100% o2 @ RA. Pt denies SOB, difficulty breathing and chest pain, remains calm watching tablet with mother. Localized redness and rashes never spread during observation, but do not dissipate and at this time I decide to take patient to urgent care and confirm plan of action with manager MA. Mother complies and approves urgent care visit.    Recommendation: I escort pt and mom to pediatric urgent care. Patient is alert, oriented, and is active running around the hallways. Mom and patient remain calm. I check in at pediatric urgent care desk and report to both desk representatives and give hand off report to RN. Patient and mom present at waiting room and wait to be called in.
nauseated shortly after receiving immunization. Vomited x 3 at home in evening a x2 this am. Headache, soft stools, fatigue, epigastric, tenderness and Right upper quadrant tender to deep palpation.
pt admit to hospital with incidental finding of COVID19 s/p 2 doses of Moderna on 12/30/20 & 1/27/21. No immunocompromised state or medications.
Pt c/o tongue swelling without difficulty breathing, EMS called . Epinephrine 0.3mg administered. EMS arrived,swelling less . After discussion with EMS and mother  pt agreed to transport to  Hospital.
1/8 - Within 12 hrs had body, eye, and headache.  Overall tired.  Could not do normal daily things without feeling wiped out . 3 Advil did nothing- sat 1/9.  Next day felt better.- sun 1/10.  That evening low grade fever 99.6 and achy again., mostly eyes and head.  Went to bed.  Monday okay. But noticed right armpit a pit puffy.- same side as injection.  Tuesday 1/12 woke up at 6:00am and had dull joint/bone pain bilaterally.  Ranging from neck ache, to sternum/upper back, shoulders, triceps.  Injection site still sore- slightly red off to the side.  Did some stretches in bed and eventually got up.  I am very in tune with my body- something is off.  I never wake up feeling ?bad?.  Fit, healthy and active normally.  Almost like a bad nights sleep with a poor mattress but only affected my upper body.  Took two Advil and hot shower- feel better but can tell something doesn?t feel right.
Bone pain; Fatigue; This case was reported by a other health professional via call center representative and described the occurrence of bone pain in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th June 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced bone pain and fatigue. On an unknown date, the outcome of the bone pain and fatigue were recovered/resolved.   It was unknown if the reporter considered the bone pain and fatigue to be related to Shingrix.  Additional case details were reported as follows: The patient complained of bone pain and fatigue for a month after receiving the second dose of Shingrix. It was reported that vaccine not administered at the physicians office. The reporter consented to follow up.
First Symptom: Wierd fast heart beating feeling but heart doesn't seem to be beating fast when I check my pulse. This started happening few days after first shot. Usually doesn't last too long but comes back randomly. Seems to be when I lay down or at night..... Second Symptom: Left ear pain. Started 6 days after first shot. Feel it most when I squat down. Feels like it is clogged. Left side of neck below ear also had pain. Came out of nowhere and all of a sudden. Family and friends have had similar issues. Some even loosing their hearing .
constipation, nocturnal enuresis, low grade VUR and voiding dysfunction.     Patient had GI managing her constipation and underwent pelvic floor therapy for the voiding dysfunction.  She was on Bactrim prophylaxis for the VUR.  In 2017 Mom still felt that patient was not voiding often and her fluid intake was low.  She only had NE once in 4 months and BMs were okay without Miralax.  VUR was only grade I bilaterally but also with a spinning top urethra (more likely to be due to voiding habits and very likely to resolve with improved habits). We hoped to repeat the VCUG in a few years once voiding was improved.  In 2018 she was doing well.  No enuresis day or night and no UTIs. She still required voiding reminders but was going about 5-6 times a day.  She was on Bactrim once a day and just stopped that. She only had BMs about 2 times a week, Miralax was only every other day and she plugged the toilet often.  She asked her to keep doing timed voiding and increase the Miralax.  She also ordered another US in 6 months and VCUG if she were to have UTIs (or in the future if no UTIs).   She was then lost to follow up.    .  The family was traveling this summer and walking many miles every day and she was complaining of fatigue and abdominal pain.  Her constipation had returned (appendicitis ruled out) and she also was diagnosed with a UTI in mid-August that did not resolve after a course of Keflex.  No fevers, just feeling poorly and abdominal pain. Even after the course of Keflex she developed dysuria and was then started on Bactrim BID for 7 days (developed hives on the back of her legs after the 5th day so she stopped them).
8x8 cm area of induration of injection site. Appeared 24 hours post vaccination. No eryteham. Non-tender.
First dose: Mild sore arm, and nothing else. Second shot: Very mild fever, chills, mild muscle aches. Third (booster): Mild chills, mild loss of apitite, mild muscle aches.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown dates, the patients were vaccinated with the unspecified number of improperly stored doses of VAQTA (lot# K018181, exp. date: 04-JUN-2017) (strength, dose and frequency were not reported). The doses of VAQTA were in temperature minus 1.2 Celsius degree for 18 hours and 32 minutes. There was no previous temperature excursion available. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
Case number PHEH2014US018776 is an initial spontaneous report received  from a physician on 18 SEP 2014, with the follow-up received on 27 OCT 2014. This report refers to an 11 year old male patient. Past medical history and concomitant medications was not reported. He was vaccinated with FLUCELVAX (batch number: 017021A) at dose of 0.5 ml in the right arm, intramuscularly on 16 SEP 2014 at 15:00 PM. No adverse reaction was reported following this administration error (inappropriate age at vaccine administration).  Follow-up received from the physician on 27 OCT 2014: Updated vaccine does, site and time of vaccination.
I have had nueropathy induced by antibiotics in the past. I have been in remission for 6 weeks after a one week reaction to St Johns Wort, but before that was in remission for a year or two. 25 hours after getting the covid vaccine last week, I started getting burning nerves, tingling, and pins and needles, which has only gotten worse in the last 3 days. There were no symptoms of this right before the vaccine.
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 18-DEC-2014, the patient was vaccinated with an improperly stored dose of GARDASIL (Lot No. K001631, exp. 06-NOV-2016) (dose and site not reported). On an unspecified dates, the GARDASIL vaccine had two temperature excursions: 24 and 48 hours respectively. The lowest recorded temperature was 34 (1.111111111 Celsius degrees). The highest recorded temperature was 47 (8.333333333 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
his arm hurt really badly; This is a spontaneous report from a contactable consumer, the Patient via Pfizer sponsored program. A male patient of an unspecified age was tested positive on December 2021. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number and Expiration date were Unknown) via an unspecified route of administration on 11Mar2021 as single dose for COVID-19 immunisation. Medical history included covid-19 from Dec2020. The patient's concomitant medications were not reported. On 11Mar2021 (the day of vaccination) patient said three hours after getting the first dose of the vaccine his arm hurt really badly. The patient was thinking not to get the second dose because he doesn't want to experience that again. Lab test included sars-cov-2 test: positive on DEC2020. The outcome of events was unknown.
patient came in 2 days after 2nd dose with localized rash around injection site (3-4" diameter). Also had had a low grade fever overnight. Began taking Benadryl to relieve itching/rash. Next day I followed up w/phone call and pt. was better but still itching w/rash
bruising on Arm; Swelling under arm; soreness in her arm; swollen lymph nodes under her arm; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruising on Arm), VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes under her arm), LYMPHADENOPATHY (Swelling under arm) and VACCINATION SITE PAIN (soreness in her arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes under her arm) and VACCINATION SITE PAIN (soreness in her arm). On 25-Apr-2021, the patient experienced CONTUSION (bruising on Arm) and LYMPHADENOPATHY (Swelling under arm). The patient was treated with Manual therapy (cold compress) for Vaccination site lymphadenopathy and Manual therapy (cold compress) for Vaccination site pain. On 02-May-2021, CONTUSION (bruising on Arm) had resolved. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes under her arm), LYMPHADENOPATHY (Swelling under arm) and VACCINATION SITE PAIN (soreness in her arm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Dec-2020, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported by the reporter.  The patient had her second dose on an unknown date and the batch number was 041b21a.  Treatment medication was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Significant follow up report received included information about the outcome of events Pain in arm and Vaccination site lymphadenopathy that was updated to not recovered. On 29-Jun-2021: Follow up report received included additional events of Bruising of arm and Swelling under arm. Lab data added
Pain, redness and swelling at the injection site - still ongoing as of 3/17/2021. Fever up 101 degrees started appx. 8pm 3/13/2021. Treated with Tylenol every six hours. Fever finally broke with a cold sweat approx. 2:00 am 3/15/2021. Chills accompanied fever evening of 3/13/2021, afternoon and evening of 3/14/2021. Loss of appetite started evening of 3/13/2021 and continues on 3/17/2021: Unable to eat anything but bland food 3/13/2021 until 3/15/2021. Still continuing with decreased appetite. Headache and muscle aches began appx. 7 pm 3/13/2021 and continued until evening of 3/15/2021, only abated with doses of Tylenol for fever every 6 hrs at that time.  Patient developed cough, similar to covid, and had to use increased oxygen from appx. 2 pm 3/14/2021 until 10:00 am 3/16/2021. Cough was treated with Robitussin every 6 hours for 3 doses and 1 bedtime dose after that.
Shingle vaccine associated myocarditis; myocardial Edema; chest pain radiating to left arm; This serious case was reported in a literature article and described the occurrence of myocarditis in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.    The patient's past medical history included gastroesophageal reflux disease.   On an unknown date, the patient received Shingrix (unknown arm). On an unknown date, 1 week after receiving Shingrix, the patient experienced myocarditis (Verbatim: Shingle vaccine associated myocarditis) (serious criteria GSK medically significant), myocardial edema (Verbatim: myocardial Edema) (serious criteria GSK medically significant) and chest pain with radiation to left arm (Verbatim: chest pain radiating to left arm). The outcome of the myocarditis, myocardial edema and chest pain with radiation to left arm were not reported.   The reporter considered the myocarditis, myocardial edema and chest pain with radiation to left arm to be related to Shingrix.     The company considered the myocarditis, myocardial edema and chest pain with radiation to left arm to be related to Shingrix.   Additional Information: GSK Receipt date: 22 Jun 2023  A 50 year old male with a history of gastroesophageal reflux disease he received the Shingrix vaccine one week prior to symptoms onset. He presented to the emergency department complaining of chest pain radiating to his left arm that started one day ago.  In the emergency department, his blood pressure was 118 79 mmHg, heart rate 63 bpm, and oxygen saturation 99 percent. Complete blood count and basic metabolic profile were within normal limits. High sensitivity troponin at baseline and one hour after the presentation were above 5000 pg per ml. The Electrocardiogram showed ST depression in leads V4 and T wave inversion on leads III, 2, 4, 5, and 6. A bedside transthoracic echocardiogram demonstrated Normal left ventricular systolic function with EF 55 perecnt, with wall motion abnormalities of the inferior wall. He underwent coronary angiography that revealed no significant disease. Cardiac MRI revealed myocardial edema and subepicardial enhancement in the basal inferior and lateral walls which meet the criteria of findings for myocarditis. On the follow up visit after two months, repeated echocardiography showed normal left ventricular systolic function with normal wall motion.
Rash at injection site, similar appearance to cellulitis; red, warm,  raised bumps. Approximate size 6"L x 3"W.
tingling in back of tongue approximately 30 minutes after injection, resolved on its own at approximately 90 minutes after injection
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. No medical history and concurrent conditions were reported from the patients. On unspecified dates between 14-OCT-2015 and 16-OCT-2015, the unspecified number of patients were vaccinated with improperly stored doses of VAQTA lot # K005958, expiration date 09-FEB-2017 (dose, frequency and route were not reported). No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports from the same source. Additional information has been requested.
Pt called call center on 6/11/21. Pt also had her husband on the line with her. Pt received Pfizer vaccine on 6/9/21. Pt has red spots on the left side of her arm, armpit and between fingers where she received the vaccine, onset just now. Pt had abdominal cramping last night for 2-3 minutes. Pt also has headache and fatigue onset yesterday. Advised pt to go to urgent care to get evaluated
On the evening of January 15th, I had a big blind spot show in my right eye.  On 1/17, I could still not see so I went to the Optometrist who ran all the tests he could but could not figure out what was wrong and referred me to an opthalmalogist.  I went to the Opthalmalogist on 1/18 who ran more tests then sent me to the ER where I was ultimately admitted.  They ran a ton of tests, confirmed optical neuritis in the right optical nerve, and ruled out that it was due to stroke or any infection.  I was released after two dosages of IV steroids with one last pill form treatment to do at home.  No change in sight.  They believe it is due to an autoimmune disease, possibly MS.
Severe right shoulder pain and deltoid tendonitis with confirmed weakness of the right arm and new limitation in right shoulder range of motion.
Several days of odd sensation of both feet along with weakness of arms but mostly weakness of legs. Sent to ER to be admitted to R/O GBS. Received Adacel for pertussis outbreak.  6/6/06 Received medical records from hospital which reveal patient experienced HA, low back pain radiating to bilateral thigh, numbness & tingling of arms & legs x 3 days.  Difficulty walking & climbing stairs, unable to run or walk fast (patient is regular runner). Treated & released from ER to f/u as outpatient.  O2 sats in ER wer 92% on RA.  Dx: probable GBS 2 wks post vax.  MRI of complete spine revealed disc bulges.  6/6/06 Received medical records from neurologist which reveal patient had nerve conduction studies which showed findings consistent w/demyelinative neuropathy compatible w/GBS.  Treated & permitted to work only 8 hrs daily (patient is an MD)/ss
This case was reported by a healthcare professional and described the occurrence of idiopathic thrombocytopenia purpura in a 7 year old male subject who was vaccinated with hepatitis A vaccine inactivated (Havrix) for prophylaxis. The subject had no pre existing medical conditions. There were no concurrent medications. On 4/14/2006 the subject received 1st dose of Havrix in the left arm (lot AHAVB090AA). On 5/1/2006, 17 days after vaccination with Havrix, the subject experienced idiopathic thrombocytopenia purpura. The subject was hospitalised and was treated with intravenous immunoglobulin. The healthcare professional considered the event was clinically significant or requiring intervention (OMIC). At the time of initial reporting, 5/2/2006, the event was ongoing. The healthcare professional considered the event to probably be related to vaccination with Havrix.
8 weeks baby received by error Kinrix; Kinrix as a first dose instead of Dtap monovalent dose and IPV monovalent dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-week-old female patient who received DTPa-IPV (Kinrix) (batch number H99J7, expiry date 26-MAY-2023) for prophylaxis.   On 10-APR-2023, the patient received the 1st dose of Kinrix. On 10-APR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 8 weeks baby received by error Kinrix) and inappropriate schedule of vaccine administered (Verbatim: Kinrix as a first dose instead of Dtap monovalent dose and IPV monovalent dose). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-APR-2023 The reporter reported that a patient received by error Kinrix as a first dose instead of Dtap monovalent dose and IPV monovalent dose. The reporter consented to follow up via email. The patient received Kinrix by error as first dose instead of Dtap monovalent dose and IPV monovalent dose which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered.
Loss of Period. I have not had a period since I received the vaccine 5 months ago.